NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

NCT04211675 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Neuroblastoma
Refractory Neuroblastoma

Interventions

BIOLOGICAL: Natural Killer Cells
DRUG: Temozolomide
DRUG: Irinotecan
DRUG: Dinutuximab
DRUG: Sargramostim

Sponsor

Nationwide Children's Hospital